Argatroban : UpdateYEH, Robert W; JANG, Ik-Kyung.The American heart journal. 2006, Vol 151, Num 6, pp 1131-1138, issn 0002-8703, 8 p.Article

An overview of the direct thrombin inhibitor argatrobanWALENGA, Jeanine M.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 9-14, issn 1424-8832, 6 p., SUP3Conference Paper

Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VIIMALHERBE, Stephan; TSUI, Ban C. H; STOBART, Kent et al.Anesthesiology (Philadelphia). 2004, Vol 100, Num 2, pp 443-445, issn 0003-3022, 3 p.Article

Changes in blood viscosity by heparin and argatrobanHITOSUGI, Masahito; NIWA, Munehiro; TAKATSU, Akihiro et al.Thrombosis research. 2001, Vol 104, Num 5, pp 371-374, issn 0049-3848Article

The Direct Thrombin Inhibitor Argatroban : A Review of Its Pharmacokinetics and Pharmacokinetic/Pharmacodynamic RelationshipsHARDER, Sebastian; KOSTER, Andreas; KLINKHARDT, Ute et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 75-80, issn 0094-6176, 6 p., SUP1Article

Ecarin chromogenic assay: A new method for quantitative determination of direct thrombin inhibitors like hirudinLANGE, U; NOWAK, G; BUCHA, E et al.Pathophysiology of haemostasis and thrombosis (Print). 2003, Vol 33, Num 4, pp 184-191, issn 1424-8832, 8 p.Article

Overview of Direct Thrombin Inhibitors in Clinical PracticeBOUNAMEAUX, Henri.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 12-17, issn 0094-6176, 6 p., SUP1Article

Effect of Argatroban versus Recombinant Hirudin on Tissue-Factor-Mediated Thrombin Generation : An in Vitro StudySAMAMA, Meyer Michel; LE FLEM, Léna; GUINET, Céline et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 87-90, issn 0094-6176, 4 p., SUP1Article

Argatroban-coupled Affi-Gel matrix for the purification of thrombin from plasmaLEFKOWITZ, Jerry B.Biotechnology and applied biochemistry. 2005, Vol 42, pp 189-192, issn 0885-4513, 4 p., 2Article

Coagulation laboratory testing in patients treated with argatrobanWALENGA, J. M; FASANELLA, A. R; IQBAL, O et al.Seminars in thrombosis and hemostasis. 1999, Vol 25, pp 61-66, issn 0094-6176, SUP1Article

The effects of argatroban on thrombin generation and hemostatic activation in vitroTANAKA, Kenichi A; SZLAM, Fania; KATORI, Nobuyuki et al.Anesthesia and analgesia. 2004, Vol 99, Num 5, pp 1283-1289, issn 0003-2999, 7 p.Article

Impact of smart infusion technology on administration of anticoagulants (Unfractionated heparin, Argatroban, Lepirudin, and Bivalirudin)FANIKOS, John; FIUMARA, Karen; BAROLETTI, Steve et al.The American journal of cardiology. 2007, Vol 99, Num 7, pp 1002-1005, issn 0002-9149, 4 p.Article

Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulationKANEMITSU, Shinji; NISHIKAWA, Masakatsu; ONODA, Koji et al.Journal of thoracic and cardiovascular surgery. 2003, Vol 126, Num 2, pp 428-435, issn 0022-5223, 8 p.Article

ArgatrobanKATHIRESAN, Sekar; SHIOMURA, Jin; JANG, Ik-Kyung et al.Journal of thrombosis and thrombolysis. 2002, Vol 13, Num 1, pp 41-47, issn 0929-5305Article

Development of argatroban as an anticoagulant and antithrombin agent in JapanIKOMA, Hidenobu.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 23-28, issn 1424-8832, 6 p., SUP3Conference Paper

Comparison of the ecarin chromogenic assay and different aPTT assays for the measurement of argatroban concentrations in plasma from healthy individuals and from coagulation factor deficient patientsSIEGMUND, Robert; BOER, Klas; POESCHEL, Katrin et al.Thrombosis research. 2008, Vol 123, Num 1, pp 159-165, issn 0049-3848, 7 p.Article

Heparinless cardiopulmonary bypass with argatroban in dogsRIKITAKE, Kazuhisa; OKAZAKI, Yukio; NAITO, Kozo et al.European journal of cardio-thoracic surgery. 2004, Vol 25, Num 5, pp 819-824, issn 1010-7940, 6 p.Article

Inhibition of osteopontin dependent carcinogenesisKAPOOR, Shailendra.Journal of cancer research and clinical oncology. 2008, Vol 134, Num 8, pp 927-928, issn 0171-5216, 2 p.Article

Drug Monitoring of Argatroban Using the Ecarin Chromogenic AssayNOWAK, Götz; LANGE, Ute; BUCHA, Elke et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 81-86, issn 0094-6176, 6 p., SUP1Article

Water-soluble argatroban for antithrombogenic surface coating of tissue-engineered cardiovascular tissuesNAKAYAMA, Yasuhide; YAMAOKA, Saori; KANDA, Keiichi et al.Journal of biomedical materials research. Part B, Applied biomaterials. 2011, Vol 99, Num 2, pp 420-430, issn 1552-4973, 11 p.Article

Clinical Experience of Argatroban in GermanyDEMPFLE, Carl-Erik.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 48-51, issn 0094-6176, 4 p., SUP1Article

Hemodialysis with a Dialyzer Loaded with Argatroban May Be Performed in vivo without a Systemic AnticoagulantYIXIONG ZHANG; JIANPING NING; VEERARAGOO, Pouranan et al.Blood purification. 2012, Vol 33, Num 4, pp 300-306, issn 0253-5068, 7 p.Article

Potency Adjusted Generic Versions of Argatroban Can Be Differentiated from Branded Argatroban in Thrombin Generation and Platelet Activation AssaysADIGUZEL, Cafer; IQBAL, Omer; CUNANAN, Josephine et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 108-118, issn 0094-6176, 11 p., SUP1Article

Effect of renal function on the pharmacodynamics of argatrobanARPINO, Paul A; HALLISEY, Robert K.The Annals of pharmacotherapy. 2004, Vol 38, Num 1, pp 25-29, issn 1060-0280, 5 p.Article

Heparin-Induced Thrombocytopenia Clinical Studies and the Efficacy of Argatroban in JapanMIYATA, Shigeki; YAMAMOTO, Haruko; KAMEI, Masataka et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 37-47, issn 0094-6176, 11 p., SUP1Article